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Roderick R. McInnes2,3,*It is indeed a great honor and personal pleasure to present
the 2014 McKusick Leadership Award of The American
Society of Human Genetics (ASHG) to David Valle, director
of the McKusick-Nathans Institute of Genetic Medicine at
The Johns Hopkins University School of Medicine. David
has been an exceptional colleague and friend for more
than 40 years. We first met when he visited the lab of
Charles Scriver atMcGill in theearly1970s, andhis comfort-
able leadership style was evident even in those early days.
Great leadersbegetothergreat leaders, andDavid’s inborn
leadership skills were epigenetically enhanced by some of
the giants of human genetics. Victor McKusick, not one
given to public displays of sentiment, would have been
visibly delighted to witness David’s receiving this recogni-
tion today. A triumvirate of role models including Victor,
Charles Scriver, and especially Barton Childs had forceful
imprints on David’s career. In his obituary of Victor, pub-
lished in The American Journal of Human Genetics in 2008,
David noted Victor’s life-long ‘‘romance with genetics, .
intellectual honesty, clarity of thinking, a willingness to
work hard, a dedication to education, and a wry sense of
humor,’’ all genetically complex traits that also capture
the essence of this year’s recipient of the McKusick Award.
David’s research has placed him at the forefront of three
disparate areas of human biology and genetics, an unusual
achievement in modern science. His first research interest
was the aminoacidopathies. In 1977 he reported his first
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deficiency. Many key publications on ornithine meta-
bolism and its associated diseases followed over the subse-
quent decades. Themost significant, undoubtedly, must be
those demonstrating that gyrate atrophy was one of the
very first treatable retinal degenerations, a milestone in
the management of inherited disease.
David’s second research direction, on disorders of perox-
isome biogenesis, was announced by a period of remark-
able productivity from 1995 to 1998. In collaboration
with Hugo Moser and Stephen Gould, he identified 5 of
the 12 genes known to be associated with these disorders.
The genes were discovered by in silico screens for human
homologs of known yeast peroxisomal genes, and their or-
thology was then established by functional complementa-
tion of human peroxisomal mutants. David’s colleague
Aravinda Chakravarti notes,
His insight into the future of human genetics could
be gauged by his championing studies of distant
model systems to unravel human disease. Themouse
is easy, but the meetings organized by [him] and Phil
Hieter, on investigating human-yeast protein homol-
ogies to understand human disease, arose from his
own work on peroxisomal disorders.
The comfortable and productive collaborations between
Gould, Moser, Hieter, and David are typical of how he in-
teracts with colleagues, interactions invariably character-
ized by his generosity in sharing ideas and credit.
In recent years, determined to identify genetic variants
that contribute to psychiatric disorders, David has turned
his attention to this third area of research. This transition,
from monogenic to complex disorders, is a challenge few
have taken up. Two beautiful recent papers illustrate the
success of his team in this domain as well, first in identi-
fying schizophrenia-associated variants in DPYSL2 and
NRG3 and then, importantly, in presenting strong biolog-
ical evidence that supports the functional significance of
these variants—a substantial contribution to our under-
standing of this important condition.
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medical genetics education, both in research and in the
clinic. In his lab, David has mentored more than 30
superbly trained biochemical geneticists, who now work
in more than 20 academic medical centers throughout
the world. Much of the research on OAT and gyrate atro-
phy was led by a postdoc, Grant Mitchell, who remembers,
In themid 1980s, Dave’s labwas one of the few places
where full-time lab training could be combined with
intense clinical learning. When I arrived, Dave was
fresh from his sabbatical with Nobel laureate Daniel
Nathans. In the Molecular Biology Department at
Hopkins, Dave’s lab was unique because of its clinical
focus. He was an unparalleled mentor who is still a
thoughtful pillar of support and inspiration.
Another former trainee, Larry Brody, recalls, ‘‘The lab had
very little hierarchy and continuous interaction. Anyone
joining with an air of superiority soon realized that science
was about what we do not yet know.’’
At Johns Hopkins, David has directed the Human Ge-
netics Predoctoral Training Program formore than 25 years
and has participated directly in the education of more than
400 graduate students, dozens of whom now have
outstanding careers of their own. Graduates of this pro-
gram are department chairs or hold important positions
at the NIH and other government agencies, in big pharma,
in law, and of course in teaching. David was an original co-
chair of the Curriculum Reform Committee at Hopkins,
and the impact of his educational philosophy will be felt
for many years, given his key role in the conceptualization,
development, and implementation of Genes to Society,
the new Hopkins medical school curriculum for the 21st
century.
In addition to playing leading roles in education at
Hopkins, David has had great influence on medical ge-
netics education both nationally and internationally.
Since 1992, he has co-directed the annual Short Course
in Medical and Experimental Mammalian Genetics—a
venerable course started by Victor McKusick more than
50 years ago and organized by Johns Hopkins and The
Jackson Laboratory. Since its inception in 1959, over
5,000 clinicians and scientists have attended the course
to learn the foundations and the latest exciting science
in human and mouse genetics. Patsy Nishina of The
Jackson Laboratory, a co-organizer of the course with
David, recalls,
I learned from my interactions with David that he is
a true Renaissance scientist, able to contribute both
breadth and depth to any scientific discussion.
Because of his deep well of knowledge, David was
always able to pitch hit on only a moment’s notice
when speakers were unable to make it for their talk.
The success of the Short Course for more than two
decades can be largely placed at David’s door.
In a second role of international significance, David was an
editor of the classic reference book on human medicalThe Amegenetics The Metabolic Basis of Inherited Disease and, since
2001, has been editor in chief of its descendant online
version The Metabolic and Molecular Bases of Inherited
Disease. His encyclopedic knowledge of molecular genetics
andmetabolism, along with the input of the entire team of
editors, helped transform that text, expanding it from
biochemistry to the molecular basis of all medicine and
ultimately bringing it to the Internet.
As a first-class clinician researcher whose contributions
have been so well balanced between the lab and the clinic,
Davidhas fewpeers. Hehas trainedmanyof themost prom-
inent clinical geneticists of the US. Ada Hamosh recalls,
At morning clinical rounds, Dave would use the So-
cratic method, prompting house staff with questions
until they couldn’t answer one. One day I decided to
read every paper on the disorder affecting the child I
had just admitted. The next morning, Dave askedme
questions for a full 45 min until I got to one I
couldn’t answer! All clinical fellows were expected
to develop the habits of rigorous thinking and
knowledge of the literature and to apply that knowl-
edge at the bedside.
David’s intellectual, interpersonal, and leadership skills
have placed him in a truly remarkable range of other
important roles in American genetics and research. These
include being president not only of the ASHG (2003) but
also of the Society for Inherited Metabolic Disorders
(1987–1989) and HUGO America (2004–2007). In addi-
tion, he has been chair of the Accreditation Committee
of the American Board of Medical Genetics (1990), chair
of the Board of Scientific Counselors of The Jackson Labo-
ratory (2010–2014), a member of the Advisory Council for
the NIH National Human Genome Research Institute
(1995–1999 and 2006–2011), and a member of the NIH
Council of Councils (2009–2012).
In closing, I want to point out that David’s closest col-
leagues regard him with great affection. Larry Brody noted,
‘‘The worst lesson I learned fromDave was thatmany dead-
lines really aren’t. He raised procrastination to a high art!’’
Similarly, Ada Hamosh recalls,
His patients never minded his being late, because
they knew that when they finally got to see Dr. Valle
they would have his undivided attention for as long
as needed. Of course, this commitment only made
him later for the next appointment. For his 50th
birthday, a long-term colleague gave him a watch
in which the numbers said 1-ish, 2-ish, etc.
This trait has become legion and is perhaps most famously
exemplified by stories of David’s late-evening desperate
drives to Bethesda—in the days before web-based submis-
sions—to deliver a grant to the NIH, by hand, at least three
min before the midnight deadline!
Please join me in welcoming David Valle as the 2014
recipient of the ASHG’s Victor A. McKusick Leadership
Award.rican Journal of Human Genetics 96, 372–373, March 5, 2015 373
